GCP

GSA Capital Partners Portfolio holdings

AUM $1.43B
1-Year Return 20.34%
This Quarter Return
-1.68%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$188M
Cap. Flow %
13.12%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Sector Composition

1 Technology 15.42%
2 Healthcare 13.31%
3 Consumer Discretionary 13.28%
4 Financials 12.51%
5 Industrials 11.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FYBR icon
2001
Frontier Communications
FYBR
$9.33B
-59,154
Closed -$1.45M
GBIO icon
2002
Generation Bio
GBIO
$40.3M
-6,424
Closed -$261K
GBX icon
2003
The Greenbrier Companies
GBX
$1.46B
-4,905
Closed -$256K
GDDY icon
2004
GoDaddy
GDDY
$20.1B
-5,620
Closed -$667K
GDS icon
2005
GDS Holdings
GDS
$6.35B
-17,302
Closed -$115K
GEF icon
2006
Greif
GEF
$3.57B
-6,716
Closed -$464K
GEN icon
2007
Gen Digital
GEN
$18.2B
-16,362
Closed -$367K
FIGS icon
2008
FIGS
FIGS
$1.12B
-73,357
Closed -$365K
FHLC icon
2009
Fidelity MSCI Health Care Index ETF
FHLC
$2.48B
-15,511
Closed -$1.08M
FHTX icon
2010
Foghorn Therapeutics
FHTX
$326M
-21,855
Closed -$147K
AA icon
2011
Alcoa
AA
$8.24B
-17,624
Closed -$596K
ABBV icon
2012
AbbVie
ABBV
$375B
-2,965
Closed -$540K
ABOS icon
2013
Acumen Pharmaceuticals
ABOS
$87.2M
-25,370
Closed -$103K
ACHR icon
2014
Archer Aviation
ACHR
$5.48B
-68,578
Closed -$317K
ACIW icon
2015
ACI Worldwide
ACIW
$5.19B
-25,487
Closed -$846K
ADAP
2016
Adaptimmune Therapeutics
ADAP
$10.9M
-370,179
Closed -$585K
ADNT icon
2017
Adient
ADNT
$2B
-9,408
Closed -$310K
ADV icon
2018
Advantage Solutions
ADV
$580M
-21,433
Closed -$93K
AEIS icon
2019
Advanced Energy
AEIS
$5.8B
-7,835
Closed -$799K
AFL icon
2020
Aflac
AFL
$57.2B
-7,348
Closed -$631K
AFRM icon
2021
Affirm
AFRM
$28.4B
-20,946
Closed -$780K
AGEN
2022
Agenus
AGEN
$138M
-63,550
Closed -$737K
AGIO icon
2023
Agios Pharmaceuticals
AGIO
$2.09B
-30,853
Closed -$902K
AKAM icon
2024
Akamai
AKAM
$11.3B
-1,866
Closed -$203K
AKRO icon
2025
Akero Therapeutics
AKRO
$3.58B
-11,116
Closed -$281K